Discovery US 2024

7 - 8 November 2024 | Boston, MA

Connecting experts in biology & chemistry to advance small molecule drug discovery

Event Page - Hero Banner 6

Explore Discovery US 2024: Fast-Tracking Novel Target Identification & Validation

As recent technological and pharmacological advances tackle the previously ‘undruggable’, Discovery US returns to support the discovery of novel pharmaceutical modalities beyond the rule of five – including novel degraders, molecular glues, orally-available peptides and radioligands.

The focussed, two-day agenda showcases the key platforms and technologies impacting early drug pipelines, from DNA-encoded libraries and phenotypic screening through to AI algorithms and organoid models. It brings together experts in target discovery and validation from across small & large biopharma organizations to discuss how the newest therapeutic paradigms can overcome historic challenges in drug development and provide optimized, novel drug candidates. Further sessions explore the use of automation to augment drug development and improve your lab productivity, showcasing the competitive advantages that can be gained in drug development through digitalization and robotics.

Discovery US 2024

  • Benefit from our revamped programme for 2024, designed to provide in-depth discussion of the key technologies, modalities & platforms transforming small molecule drug discovery  
  • Discover emerging drug targets beyond the rule of five, from Induced Proximity & Molecular Glues through to siRNAs and orally-available peptides, with case studies on the chemical & biological considerations of developing these complex molecules
  • Enable your lab to operate at peak productivity. Maximize your R&D capabilities with integration of advanced robotics & automation, as well as utilizing AI to augment your drug development

Agenda at a Glance

  • Day One | Track 1: Novel Targets Beyond The Rule Of Fives
  • Day One | Track 2: Novel Models For ADME-Tox Research & Disease Modelling 
  • Day One | Track 3: Augmenting R&D With AI and Automation
  • Day Two | Track 1: Innovative Technologies For Hit Identification & Screening
  • Day Two | Track 2: Computational & Medicinal Chemistry
  • Day Two | Track 3: Genomics-Driven Drug Discovery & Bioinformatics

What to Expect


leading pharma, biotech & academic delegates

hours of presentations, discussions & interactive content
hours of networking breaks, including speed networking & refreshments
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 75 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Discovery US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Aaron Van Hooser
Senior Director, Computational Biology,
Sensorium Therapeutics
Abhijat Vatsyayan
Head of Artificial Intelligence,
Taiho Oncology
Divya Kanichar
Fiona Mack
Vice President,
Hong Cheng
Vice President, Head of Research Strategy,
Ilkay Us
Director, High Throughput Screening,
Cornell University
Jason Ekert
Head of US Translational Technology,
Jennifer Busby
Director - Academic Affairs, Biology,
Julie Owen
Recursion Pharmaceuticals
Lihua Yu
Chief Data Officer,
LifeMine Therapeutics
Martin Redhead
Associate Vice President,
Paul Scola
Senior Director, Chemistry,
Bristol Myers Squibb
Boguslaw Nocek
Senior Director,
Eli Lilly
Gvido Cebers
Global Head of Drug Safety & Evaluation,
Joseph Wu
Director, Stanford Cardiovascular Institute and Professor, Department of Medicine/Cardiology & Radiology,
Stanford University
Judith Ronau
Senior Scientist,
Kian Tan
Lena Dolgikh
Head of CADD,
Monte Rosa Therapeutics
Noel Powell
Senior Director -Medicinal Chemistry,
Recursion Pharmaceuticals
Prashant Gahtori
Graphic Era Hill University
Shuying He
Senior Director, External Innovation,
Eli Lilly
Yuan Wang
Head, Research Analytics,

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Alzheimer's & Brain Awareness Month Spotlight: How Amphista Therapeutics is Tackling Neurological Disorders

To honour Alzheimer's & Brain Awareness Month, this article will acknowledge Amphista Therapeutics' use of targeted protein degradation (TPD) to treat symptoms of neurological disorders.

New Class of Molecular Glues Could Reshape Cancer Drug Discovery

A research group at the University of Dundee discovered new molecular glues, expanding the targeted protein degradation field.

Advancing Cervical Cancer Treatment: FDA Approves Roche's New Self-Collection Option for HPV Testing

The FDA approves a new self-collection test to detect human papillomavirus and identify women at risk for cervical cancer.

Euroscreen Fast Assay Development and High-Throughput Screening Services

Pelago Bioscience - CETSA® Technology

New Trailblazer Profluent Launches its AI-enabled OpenCRISPR-1 to Edit the Human Genome

Profluent successfully combined large language models (LLMs) and CRISPR for an open-source AI gene editing project which could reshape CRISPR treatment options.

Plan Your Visit

Boston Marriott Cambridge
50 Broadway, Cambridge, MA 02142, United States

Public Transportation:

The nearest Bus station is South Station
The nearest Subway station is Kendall/MIT
The nearest Train stations are North Station and South Station
For more information, please click here.


By Air: 

Boston Logan International Airport is the nearest airport to the venue – 5 miles from the property. 
For more information, please call +1 800-2356426 or click here.



On site valet parking: $58.99 (valet with in/out privileges)
Off site self-parking: $48.00 daily (no in/out privileges)

Information regarding accommodation for this event will be added soon

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Discovery US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch